Healthways, Inc. (NASDAQ:TVTY) had its price target lifted by Oppenheimer Holdings, Inc. from $47.00 to $50.00 in a research note published on Wednesday. The brokerage currently has an outperform rating on the stock. Oppenheimer Holdings also issued estimates for Healthways’ Q4 2017 earnings at $0.32 EPS, Q2 2018 earnings at $0.43 EPS, Q3 2018 earnings at $0.43 EPS, Q3 2018 earnings at $0.44 EPS, Q4 2018 earnings at $0.41 EPS, FY2018 earnings at $1.70 EPS, Q1 2019 earnings at $0.46 EPS, Q1 2019 earnings at $0.51 EPS, Q2 2019 earnings at $0.47 EPS, Q2 2019 earnings at $0.49 EPS, Q3 2019 earnings at $0.48 EPS, Q3 2019 earnings at $0.49 EPS, FY2019 earnings at $1.89 EPS and FY2019 earnings at $1.98 EPS.
Other equities research analysts have also recently issued reports about the stock. SunTrust Banks, Inc. set a $50.00 price target on shares of Healthways and gave the stock a buy rating in a research report on Friday, October 27th. ValuEngine raised shares of Healthways from a hold rating to a buy rating in a research report on Friday, September 1st. Jefferies Group LLC reissued a buy rating and set a $46.00 price target on shares of Healthways in a research report on Monday, September 25th. Zacks Investment Research raised shares of Healthways from a hold rating to a buy rating and set a $52.00 price target on the stock in a research report on Tuesday. Finally, Chardan Capital reissued a neutral rating and set a $44.00 price target (up from $40.00) on shares of Healthways in a research report on Friday, October 27th. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of Buy and a consensus target price of $46.38.
Shares of Healthways (TVTY) opened at $48.05 on Wednesday. The company has a current ratio of 0.60, a quick ratio of 0.61 and a debt-to-equity ratio of 0.02. The stock has a market cap of $1,837.16, a P/E ratio of 28.32, a PEG ratio of 2.64 and a beta of 0.27.
Healthways (NASDAQ:TVTY) last issued its quarterly earnings results on Thursday, October 26th. The company reported $0.46 EPS for the quarter, topping the consensus estimate of $0.36 by $0.10. Healthways had a net margin of 11.45% and a return on equity of 30.23%. The firm had revenue of $137.70 million for the quarter, compared to analysts’ expectations of $137.95 million. Healthways’s revenue for the quarter was up 10.2% compared to the same quarter last year. analysts anticipate that Healthways will post 1.6 EPS for the current year.
COPYRIGHT VIOLATION WARNING: This news story was first published by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was illegally copied and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this news story can be accessed at https://www.com-unik.info/2017/11/04/oppenheimer-holdings-inc-boosts-healthways-inc-tvty-price-target-to-50-00.html.
In other news, insider Mary Flipse sold 1,340 shares of the company’s stock in a transaction dated Friday, August 11th. The shares were sold at an average price of $37.32, for a total value of $50,008.80. Following the sale, the insider now directly owns 75,187 shares of the company’s stock, valued at approximately $2,805,978.84. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, insider Glenn Hargreaves sold 7,137 shares of the company’s stock in a transaction dated Tuesday, September 26th. The shares were sold at an average price of $40.00, for a total transaction of $285,480.00. Following the completion of the sale, the insider now directly owns 52,180 shares in the company, valued at $2,087,200. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 59,558 shares of company stock worth $2,307,123. 8.42% of the stock is owned by insiders.
Institutional investors and hedge funds have recently made changes to their positions in the stock. Flinton Capital Management LLC grew its stake in Healthways by 63.5% in the 2nd quarter. Flinton Capital Management LLC now owns 3,502 shares of the company’s stock valued at $139,000 after buying an additional 1,360 shares during the last quarter. Riverhead Capital Management LLC grew its stake in Healthways by 69.7% in the 2nd quarter. Riverhead Capital Management LLC now owns 3,564 shares of the company’s stock valued at $142,000 after buying an additional 1,464 shares during the last quarter. Karp Capital Management Corp acquired a new position in Healthways in the 1st quarter valued at about $225,000. UBS Asset Management Americas Inc. acquired a new position in Healthways in the 1st quarter valued at about $242,000. Finally, California Public Employees Retirement System acquired a new position in Healthways in the 1st quarter valued at about $247,000.
Tivity Health, Inc, formerly Healthways, Inc, is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans.
What are top analysts saying about Healthways Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Healthways Inc. and related companies.